S.I.N. offers a range of products to carry out dental implant procedures. Credit: Elena Mozhvilo on Unsplash.

Henry Schein has reached an agreement for the acquisition of Brazilian company S.I.N. Implant System from the Southern Cross Group for an undisclosed sum.

S.I.N. is engaged in the manufacturing of a wide range of products to carry out dental implant procedures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company, established in 2003, is primarily focused on advancing value-priced dental implant development.

Recently, the company has extended the supply of its products to the US and other major global markets.

The deal will allow Henry Schein, which has been providing services to dental practitioners in Brazil since 2014, to enter the country’s dental implant market.

S.I.N. president Felipe Leonard said: “By joining forces with Henry Schein, a world leader in dental products and related services, we will accelerate our growth in Brazil as well as advance our global expansion.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Subject to approval by Brazil’s Administrative Council for Economic Defense, the deal is expected to be completed in the second half of this year.

After the completion of the deal, S.I.N. will be included in Henry Schein’s Global Oral Reconstruction Group.

The group also comprises BioHorizons, Camlog, Biotech Dental and Medentis Medical, which offer dental implant systems and restorative components along with a comprehensive range of biologics products and digital solutions.

Henry Schein board chairman and CEO Stanley Bergman said: “The acquisition of S.I.N. represents the natural progression of our BOLD+1 Strategy to expand our fast-growing dental specialities businesses, where we have a proven track record of successful acquisitions resulting in profitable growth in addition to our internal growth.”